Both HLA-DRA and TCN1 are highly expressed in whole blood, while the mRNA levels in brain are very low or non-existent (www.gtexportal.org), suggesting that the use of blood in addition to brain tissue could be important in order to achieve a complete transcriptomic profiling of brain disorders. Here, HLA-DRA is linked to brain disorder.